Cercle
- Company typePrivate
- Founded2023
- HeadquartersFrisco, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
Cercle firmographics
Firmographics- Name
- Cercle
- Legal name
- Cercle.AI, Inc.
- Website
- https://cercle.ai
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Cercle industry classification
Industry- Product category
- Healthcare AI / Women's Health Data Intelligence
- NAICS
- Software Publishers (5132), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)
- akta.pro secondary industries
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Knowledge Management & Scientific Collaboration / Literature Intelligence (HLAGAJAN)
Keywords
Where Cercle is headquartered
LocationHeadquarters
- HQ city
- Frisco
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Cercle business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- AI Platform/SaaS Subscription: AI-powered platform providing data insights to healthcare providers and life science teams, likely delivered as a subscription or usage-based SaaS model.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Cercle product offering
Product offeringCore offering
Cercle sells an AI-enabled SaaS platform — the Cercle Biomedical Graph™ — that ingests, anonymizes, and harmonizes fragmented multimodal clinical data (genomic, EMR, imaging, notes, prescriptions) into a population-scale biomedical graph used by fertility clinics and life science teams for cohort discovery, embryo selection, predictive modeling, and clinical decision support. The platform is sold primarily to enterprise healthcare providers and life science organizations via a Book Demo / quote-based motion, with sub-products including the Fertility AI Tool, Predictor AI Tool, and a beta patient companion app called Luce.
Product overview
Cercle offers a unified AI platform called the Cercle Biomedical Graph™ for women's healthcare data intelligence. The platform architecture consists of three core components: the Ingestion Engine (which anonymizes and harmonizes multimodal clinical data), the Biomedical Graph (a multidimensional, population-scale representation connecting patients, events, and outcomes), and the Intelligence Layer (providing prediction, modeling, and decision support). The platform includes two specific AI tools — the Fertility AI Tool and Predictor AI Tool — as sub-products that help clinicians with embryo selection and treatment personalization in fertility care. The company also offers Luce, a patient-facing fertility companion app currently in beta. The platform transforms fragmented, unstructured healthcare data into real-time, high-quality insights used by healthcare providers, life science teams, and patients.
Differentiator
Problem solved
Functional benefit
Brands
- Cercle Biomedical Graph: AI-powered platform that transforms fragmented healthcare data into harmonized, anonymized insights by connecting patients, events, and outcomes across time, protocol, and clinical context.
- Cercle Intelligence Stack
- Luce
- Fertility AI Tool
Products and services
- Cercle Biomedical Graph Foundational AI platform that transforms fragmented healthcare data into a multidimensional, population-scale representation connecting patients, events, and outcomes across time, protocol, and clinical context for insight generation. Sold to enterprise healthcare providers and life science teams.
- Fertility AI Tool AI tool that connects data from all treatment stages of an IVF cycle and compares patient data with similar profiles and embryo characteristics from the Biomedical Graph to help clinicians make embryo selection decisions and develop personalized treatments. Targeted at fertility clinicians.
- Predictor AI Tool AI-powered predictive tool that uses anonymized patient data and population-scale insights from the Biomedical Graph to forecast fertility treatment outcomes. Targeted at fertility clinicians and care teams.
- Luce Beta-version fertility companion app for patients and clinicians that analyzes data from thousands of treatment cycles using the Biomedical Graph to deliver personalized insights based on similar fertility journeys. Targeted at women undergoing fertility treatment and their doctors.
Quantifiable outcome
- Analyzed more than 1 billion data points from anonymized patients globally
- +2 more outcomes
Companies that use Cercle
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Cercle technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability10 records
Feature5 records
Cercle partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and supporting.
- Ivy FertilitycoreIvy Fertility chose Cercle as its data & AI/ML partner, implementing Cercle's platform across its nationwide clinic network of 14 fertility clinics. Partnership aims to improve patient outcomes, increase ART conversion, and streamline operations across clinical and administrative teams.
- MedITEXcoreStrategic partnership with MedITEX, the leading fertility EMR provider in Europe with 600+ partner clinics across 50+ countries. MedITEX will distribute Cercle's AI platform across its global network of fertility clinics.
- Eurofins GenomacorePartnership to bring Cercle Fertility AI Tool to hundreds of fertility and genetics clinics across Europe. Combining Eurofins' PGT and genomics data with Cercle's Biomedical Graph to improve IVF outcomes and personalize treatments.
- US FertilitycoreEarly partner using the Cercle Biomedical Graph to organize unstructured, de-identified clinical data for analysis. Partnership optimizes research and internal quality assurance capabilities.
- Boston IVFsupportingEarly customer using the Cercle Biomedical Graph since launch in November 2023 to drive efficiency and inform personalized treatments.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Cercle competitors and assessment
Company assessmentDirect peers
- Tempus AI: AI-enabled precision medicine data platform serving providers and life sciences with multimodal clinical and molecular data. Highly comparable to Cercle's Biomedical Graph architecture and dual-provider/life-science GTM motion, though Tempus focuses on oncology rather than women's health.
- Flatiron Health: Real-world clinical and genomic data platform for oncology, acquired by Roche. Operates the same fundamental model as Cercle: aggregating fragmented EMR data into structured datasets for provider decision support and life science R&D.
- Komodo Health: Healthcare data analytics platform that maps patient journeys using de-identified data for life sciences and providers. Directly comparable to Cercle's patient-journey graph approach and life-science customer segment.
- Verana Health: Specialty-focused real-world data platform that integrates with specialty EHRs (including ophthalmology and neurology) to deliver curated datasets to life sciences. Closely comparable to Cercle's fertility-EMR partnership model with MedITEX.
- Aetion: Real-world evidence platform used by life sciences and regulators to evaluate treatment effectiveness. Comparable to Cercle's life-science use cases around cohort discovery, trial design, and R&D acceleration.
- Datavant: Healthcare data connectivity and de-identification infrastructure that links fragmented patient records across providers. Comparable to Cercle's Ingestion Engine layer that anonymizes and harmonizes multimodal clinical data.
Emerging players
- Atropos Health: AI-driven real-world evidence platform that generates clinician-grade observational studies from electronic health records. Comparable in its use of AI agents and NLP to surface clinical insights from fragmented data, though focused on provider decision support.
- Owkin: AI platform combining federated learning and multimodal patient data to support life sciences R&D and clinical research. Comparable AI-first architecture and life-science customer focus, though with different data-sharing and training approach.
Regional players
- Carrot Fertility: Fertility-focused benefits and care-navigation platform serving employers and patients. Comparable end market (fertility) but operates as a patient-facing benefits provider rather than a data/AI infrastructure layer like Cercle.
- Maven Clinic: Digital women's and family health platform serving employers and payers across fertility, maternity, and menopause. Comparable women's health vertical focus but delivers care rather than data infrastructure for clinics and life sciences.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Cercle compliance and trust
Trust signalCompliance2 records
Cercle financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cercle leadership team
Management profileNumber of profiles
Profiles7 records
Cercle funding detail
Funding detailFunding overview
Funding rounds1 record
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cercle M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cercle
What does Cercle do?
Cercle sells an AI-enabled SaaS platform — the Cercle Biomedical Graph™ — that ingests, anonymizes, and harmonizes fragmented multimodal clinical data (genomic, EMR, imaging, notes, prescriptions) into a population-scale biomedical graph used by fertility clinics and life science teams for cohort discovery, embryo selection, predictive modeling, and clinical decision support. The platform is sold primarily to enterprise healthcare providers and life science organizations via a Book Demo / quote-based motion, with sub-products including the Fertility AI Tool, Predictor AI Tool, and a beta patient companion app called Luce.
Is Cercle a public or private company?
Cercle is a private company. It is classified as venture growth investor backed and is currently operating.
When was Cercle founded?
Cercle was founded in 2023. It employs 11 to 50 people.
Where is Cercle based?
Cercle is headquartered in Frisco, United States, in the North America region.
How does Cercle make money?
One revenue line is on record: AI Platform/SaaS Subscription.
Who are Cercle's main competitors?
Direct peers on record are Tempus AI, Flatiron Health, Komodo Health, Verana Health, Aetion and Datavant. Emerging players are Atropos Health and Owkin. Regional players are Carrot Fertility and Maven Clinic.
Does Cercle have an API?
No public API is recorded for Cercle.
What industry is Cercle in?
Cercle's product category is Healthcare AI / Women's Health Data Intelligence. Its primary akta.pro industry code is HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D), with a secondary code of HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 5132 and its SIC code is 7372.